9474 related articles for article (PubMed ID: 19951637)
1. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
2. Investment in new technology research can save future health care dollars.
Reintgen D; Albertini J; Milliotes G; Marshburn J; Cruse CW; Rapaport D; Berman C; Glass F; Fensske N; Einstein AB; Lyman G
J Fla Med Assoc; 1997 Mar; 84(3):175-81. PubMed ID: 9143169
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
4. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
Chevalier J; Bonastre J; Avril MF
Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
6. Cumulative cost pattern comparison of prostate cancer treatments.
Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
[TBL] [Abstract][Full Text] [Related]
7. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
8. [Costs of initial cancer care and its affecting factors].
Kim SY; Kim SG; Park JH; Park EC
J Prev Med Public Health; 2009 Jul; 42(4):243-50. PubMed ID: 19675401
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
10. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
11. [Descriptive study of the costs of diagnosis and treatment of cutaneous melanoma].
Almazán-Fernández FM; Serrano-Ortega S; Moreno-Villalonga JJ
Actas Dermosifiliogr; 2009 Nov; 100(9):785-91. PubMed ID: 19889300
[TBL] [Abstract][Full Text] [Related]
12. An estimate of the annual direct cost of treating cutaneous melanoma.
Tsao H; Rogers GS; Sober AJ
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809
[TBL] [Abstract][Full Text] [Related]
13. [Advanced breast cancer: an evaluation of the cost of recurrence].
Bercez C; Lebrun T; Bonneterre ME; Selke B; Lenne X; Bonneterre J
Bull Cancer; 1999 Jun; 86(6):585-90. PubMed ID: 10417432
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
[TBL] [Abstract][Full Text] [Related]
15. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
17. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma.
Oestreicher N; Ramsey SD; McCune JS; Linden HM; Veenstra DL
Cancer; 2005 Nov; 104(10):2054-62. PubMed ID: 16216002
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
19. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.
Leiter U; Marghoob AA; Lasithiotakis K; Eigentler TK; Meier F; Meisner C; Garbe C
Melanoma Res; 2009 Feb; 19(1):50-7. PubMed ID: 19430406
[TBL] [Abstract][Full Text] [Related]
20. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
